Barrow Hanley Mewhinney & Strauss LLC / CVS
Barrow Hanley Mewhinney & Strauss LLC’s Cvs Health Corp Position
Does Barrow Hanley Mewhinney & Strauss LLC own Cvs Health Corp (CVS)? Not currently — the last reported position was 305.4K shares worth $23M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$23M
Q3 2025
Shares
305.4K
% of Portfolio
+0.07%
Quarters Held
28
position exited
Position History CVS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 305.4K | $23M | +0.07% |
| Q2 2025 | 420.0K | $29M | +0.10% |
| Q1 2025 | 455.2K | $31M | +0.11% |
| Q4 2024 | 479.0K | $22M | +0.07% |
| Q3 2024 | 493.3K | $31M | +0.10% |
| Q2 2024 | 701.6K | $41M | +0.14% |
| Q1 2024 | 2.58M | $206M | +0.69% |
| Q4 2023 | 3.20M | $252M | +0.89% |
| Q3 2023 | 4.82M | $336M | +1.29% |
| Q2 2023 | 4.54M | $314M | +1.17% |
| Q1 2023 | 4.75M | $353M | +1.37% |
| Q4 2022 | 4.36M | $406M | +1.52% |
| Q3 2022 | 4.46M | $425M | +1.74% |
| Q2 2022 | 4.58M | $424M | +1.60% |
| Q1 2022 | 4.73M | $479M | +1.56% |
| Q4 2021 | 4.94M | $510M | +1.61% |
| Q3 2021 | 6.02M | $511M | +1.69% |
| Q2 2021 | 6.34M | $529M | +1.70% |
| Q1 2021 | 6.74M | $507M | +1.61% |
| Q4 2020 | 8.38M | $572M | +1.97% |
| Q3 2020 | 9.43M | $551M | +2.12% |
| Q2 2020 | 9.66M | $627M | +2.46% |
| Q1 2020 | 11.18M | $663M | +3.04% |
| Q4 2019 | 10.92M | $811M | +2.60% |
| Q3 2019 | 16.88M | $1.1B | +2.09% |
| Q2 2019 | 17.09M | $931M | +1.70% |
| Q1 2019 | 17.15M | $925M | +1.67% |
| Q4 2018 | 19.17M | $1.3B | +2.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Barrow Hanley Mewhinney & Strauss LLC’s full portfolio or all institutional holders of CVS.